Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia.
Lipotek Pty Ltd, Canberra, ACT 2601, Australia.
Vaccine. 2021 Mar 19;39(12):1746-1757. doi: 10.1016/j.vaccine.2021.02.010. Epub 2021 Feb 20.
Merozoite surface protein 2 (MSP2) is a highly abundant, GPI-anchored surface antigen on merozoites of the malaria parasite Plasmodium falciparum. It consists of highly conserved N- and C-terminal domains, and a central polymorphic region that allows all MSP2 alleles to be categorized into the 3D7 or FC27 family. Previously it has been shown that epitope accessibility differs between lipid-bound and lipid-free MSP2, suggesting that lipid interactions modulate the conformation and antigenicity in a way that may better mimic native MSP2 on the merozoite surface. Therefore, we have immunised mice with MSP2 engrafted onto liposomes using a C-terminal tether that mimics the native GPI anchor. To improve the immunogenicity of the formulated antigen, liposomes were supplemented with Pathogen Associated Molecular Pattern molecules, specifically agonists of the Toll-like receptor 4 (TLR4) or TLR2. Induced antibodies were directed mostly towards conserved epitopes, predominantly in the conserved C-terminal region of MSP2. We also found that immunisation with a combination of 3D7 and FC27 MSP2 enhanced antibody responses to conserved epitopes, and that the overall responses of mice immunised with MSP2-engrafted liposomes were comparable in magnitude to those of mice immunised with MSP2 formulated in Montanide ISA720. The antibodies elicited in mice by immunising with MSP2-engrafted liposomes recognised the native form of parasite MSP2 on western blots and were found to be cross-reactive with isolated 3D7 and FC27 merozoites when investigated by ELISA. The liposome-tethered MSP2 induced higher titres of complement-fixing antibodies to 3D7 and FC27 MSP2 than did MSP2 formulated in Montanide ISA720. Our results indicate that liposomal formulation represents a viable strategy for eliciting a strong immune response that favours conserved epitopes in MSP2 and thus a strain-transcendent immune response.
裂殖子表面蛋白 2(MSP2)是疟原虫恶性疟原虫裂殖子表面高度丰富的 GPI 锚定表面抗原。它由高度保守的 N 和 C 末端结构域以及一个中央多态区组成,该多态区允许所有 MSP2 等位基因分为 3D7 或 FC27 家族。以前已经表明,脂结合和无脂 MSP2 之间的表位可及性不同,这表明脂质相互作用以一种可能更好地模拟裂殖子表面天然 MSP2 的方式调节构象和抗原性。因此,我们使用模拟天然 GPI 锚的 C 末端系链将 MSP2 嫁接在脂质体上来免疫小鼠。为了提高配方抗原的免疫原性,脂质体中补充了病原体相关分子模式分子,特别是 Toll 样受体 4(TLR4)或 TLR2 的激动剂。诱导的抗体主要针对保守表位,主要位于 MSP2 的保守 C 末端区域。我们还发现,用 3D7 和 FC27 MSP2 的混合物免疫可增强对保守表位的抗体反应,并且用嫁接在脂质体上的 MSP2 免疫的小鼠的总体反应与用 Montanide ISA720 配制的 MSP2 免疫的小鼠的反应相当。用嫁接在脂质体上的 MSP2 免疫的小鼠中产生的抗体在 Western blot 上识别寄生虫 MSP2 的天然形式,并在通过 ELISA 研究时发现与分离的 3D7 和 FC27 裂殖子交叉反应。与在 Montanide ISA720 中配制的 MSP2 相比,脂质体连接的 MSP2 诱导针对 3D7 和 FC27 MSP2 的补体结合抗体的滴度更高。我们的结果表明,脂质体制剂代表了一种可行的策略,可以引起强烈的免疫反应,有利于 MSP2 中的保守表位,从而产生跨株免疫反应。